117 related articles for article (PubMed ID: 29463373)
1. Novel Application of Cell Penetrating R11 Peptide for Diagnosis of Bladder Cancer.
Du Y; Wang L; Wang W; Guo T; Zhang M; Zhang P; Zhang Y; Wu K; Li A; Wang X; He J; Fan J
J Biomed Nanotechnol; 2018 Jan; 14(1):161-167. PubMed ID: 29463373
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of a cell penetrating peptide modified superparamagnetic iron oxide and MRI detection of bladder cancer.
Ding C; Wu K; Wang W; Guan Z; Wang L; Wang X; Wang R; Liu L; Fan J
Oncotarget; 2017 Jan; 8(3):4718-4729. PubMed ID: 27902468
[TBL] [Abstract][Full Text] [Related]
3. R11, a novel cell-permeable peptide, as an intravesical delivery vehicle.
Hsieh JT; Zhou J; Gore C; Zimmern P
BJU Int; 2011 Nov; 108(10):1666-71. PubMed ID: 21453348
[TBL] [Abstract][Full Text] [Related]
4. Inhibiting bladder tumor growth with a cell penetrating R11 peptide derived from the p53 C-terminus.
Zhang T; Wu K; Ding C; Sun K; Guan Z; Wang X; Hsieh JT; He D; Fan J
Oncotarget; 2015 Nov; 6(35):37782-91. PubMed ID: 26462022
[TBL] [Abstract][Full Text] [Related]
5. Importin-11 overexpression promotes the migration, invasion, and progression of bladder cancer associated with the deregulation of CDKN1A and THBS1.
Zhao J; Shi L; Zeng S; Ma C; Xu W; Zhang Z; Liu Q; Zhang P; Sun Y; Xu C
Urol Oncol; 2018 Jun; 36(6):311.e1-311.e13. PubMed ID: 29602637
[TBL] [Abstract][Full Text] [Related]
6. A new non-muscle-invasive bladder tumor-homing peptide identified by phage display in vivo.
Yang X; Zhang F; Luo J; Pang J; Yan S; Luo F; Liu J; Wang W; Cui Y; Su X
Oncol Rep; 2016 Jul; 36(1):79-89. PubMed ID: 27221614
[TBL] [Abstract][Full Text] [Related]
7. A cell permeable peptide analog as a potential-specific PET imaging probe for prostate cancer detection.
Hao G; Zhou J; Guo Y; Long MA; Anthony T; Stanfield J; Hsieh JT; Sun X
Amino Acids; 2011 Nov; 41(5):1093-101. PubMed ID: 20221650
[TBL] [Abstract][Full Text] [Related]
8. R11 modified tumor cell membrane nanovesicle-camouflaged nanoparticles with enhanced targeting and mucus-penetrating efficiency for intravesical chemotherapy for bladder cancer.
Zheng B; Liu Z; Wang H; Sun L; Lai WF; Zhang H; Wang J; Liu Y; Qin X; Qi X; Wang S; Shen Y; Zhang P; Zhang D
J Control Release; 2022 Nov; 351():834-846. PubMed ID: 36191674
[TBL] [Abstract][Full Text] [Related]
9. ISYNA1 is overexpressed in bladder carcinoma and regulates cell proliferation and apoptosis.
Guo X; Li HH; Hu J; Duan YX; Ren WG; Guo Q; Liu PH; Cui Y; Liu LF; Chen MF; Chen JB; Zu XB
Biochem Biophys Res Commun; 2019 Nov; 519(2):246-252. PubMed ID: 31495492
[TBL] [Abstract][Full Text] [Related]
10. Use of fluorescein isothiocyanate-human serum albumin for the intravesical photodiagnosis of non-muscle-invasive bladder cancer: an in vitro study using multicellular spheroids composed of normal human urothelial and urothelial cell carcinoma cell lines.
Roelants M; Van Cleynenbreugel B; Van Poppel H; Lerut E; de Witte PA
BJU Int; 2011 Aug; 108(3):455-9. PubMed ID: 21156021
[TBL] [Abstract][Full Text] [Related]
11. Analysis of oligo-arginine cell-permeable peptides uptake by prostate cells.
Zhou J; Liu W; Pong RC; Hao G; Sun X; Hsieh JT
Amino Acids; 2012 Apr; 42(4):1253-60. PubMed ID: 21120551
[TBL] [Abstract][Full Text] [Related]
12. Antisense Bcl-2 oligonucleotide uptake in human transitional cell carcinoma.
Duggan BJ; Cotter FE; Kelly JD; Hamilton PW; McCallion K; Harkin D; Gardiner T; Anderson N; Keane PF; Johnston SR; Williamson KE
Eur Urol; 2001 Dec; 40(6):685-95. PubMed ID: 11805418
[TBL] [Abstract][Full Text] [Related]
13. Decreased TRPM7 inhibits activities and induces apoptosis of bladder cancer cells via ERK1/2 pathway.
Cao R; Meng Z; Liu T; Wang G; Qian G; Cao T; Guan X; Dan H; Xiao Y; Wang X
Oncotarget; 2016 Nov; 7(45):72941-72960. PubMed ID: 27662662
[TBL] [Abstract][Full Text] [Related]
14. [Preliminary screening and identification of a peptide that binds specifically to gastric cancers cells with high metastasis to peritoneum].
Bai FH; Wang J; Zhao PT; Cao SS; Lei T; Li Y; Wu KC; Fan DM
Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(10):659-63. PubMed ID: 16681920
[TBL] [Abstract][Full Text] [Related]
15. Detection of survivin expression in bladder cancer and renal cell carcinoma using specific monoclonal antibodies.
Chen D; Xu J; Zhang Q
Oncol Rep; 2018 Jun; 39(6):2817-2828. PubMed ID: 29658613
[TBL] [Abstract][Full Text] [Related]
16. Prostate cancer-specific thermo-responsive polymer-coated iron oxide nanoparticles.
Wadajkar AS; Menon JU; Tsai YS; Gore C; Dobin T; Gandee L; Kangasniemi K; Takahashi M; Manandhar B; Ahn JM; Hsieh JT; Nguyen KT
Biomaterials; 2013 May; 34(14):3618-25. PubMed ID: 23419645
[TBL] [Abstract][Full Text] [Related]
17. Combined Self-Assembled Hendeca-Arginine Nanocarriers for Effective Targeted Gene Delivery to Bladder Cancer.
Zhang P; Zhang H; Zheng B; Wang H; Qi X; Wang S; Liu Z; Sun L; Liu Y; Qin X; Fan W; Ma M; Lai WF; Zhang D
Int J Nanomedicine; 2022; 17():4433-4448. PubMed ID: 36172006
[TBL] [Abstract][Full Text] [Related]
18. T24 HRAS transformed NIH/3T3 mouse cells (GhrasT-NIH/3T3) in serial tumorigenic in vitro/in vivo passages give rise to increasingly aggressive tumorigenic cell lines T1-A and T2-A and metastatic cell lines T3-HA and T4-PA.
Ray DB; Merrill GA; Brenner FJ; Lytle LS; Lam T; McElhinney A; Anders J; Rock TT; Lyker JK; Barcus S; Leslie KH; Kramer JM; Rubenstein EM; Pryor Schanz K; Parkhurst AJ; Peck M; Good K; Granath KL; Cifra N; Detweiler JW; Stevens L; Albertson R; Deir R; Stewart E; Wingard K; Richardson MR; Blizard SB; Gillespie LE; Kriley CE; Rzewnicki DI; Jones DH
Exp Cell Res; 2016 Jan; 340(1):1-11. PubMed ID: 26254261
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the therapeutic potential of the epidermal growth factor receptor tyrosine kinase inhibitor gefitinib in preclinical models of bladder cancer.
Dominguez-Escrig JL; Kelly JD; Neal DE; King SM; Davies BR
Clin Cancer Res; 2004 Jul; 10(14):4874-84. PubMed ID: 15269164
[TBL] [Abstract][Full Text] [Related]
20. Intra-colonic administration of a polymer-bound NIRF probe for improved colorectal cancer detection during colonoscopy.
Kogan-Zviagin I; Shamay Y; Nissan A; Sella-Tavor O; Golan M; David A
J Control Release; 2014 Oct; 192():182-91. PubMed ID: 25008468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
